Parkview Health, a community-based health system with 10 hospitals and a network of primary care and specialty physicians in northeast Indiana and northwest Ohio, recognized a specific and urgent need for more efficient diabetes care in fewer visits for their 1.3 million and growing patient population.
Parkview Health is committed to making healthcare accessible for their entire patient population regardless of where the patient lives, their health status, or their ability to pay. Artificial intelligence (AI) tools can empower healthcare providers to expand patient care at each visit and reduce care gaps. Parkview Health identified AI as a transformational way to achieve such equity goals.
Traditionally, patients with diabetes require an annual checkup and a separate referral appointment for a comprehensive eye exam to identify potential diabetic eye disease, such as diabetic retinopathy. Many of those patients struggle to manage multiple care appointments due to transportation issues, the need to take time off work, and more. Increased cost and lack of access can create serious barriers and deter high-risk patients with diabetes from getting the care they need. Such a delay in diabetes vision care can result in irreversible vision loss or other damage to the eyes, including blindness.
By adopting LumineticsCore™ (formerly IDx-DR), an AI diagnostic system that autonomously diagnoses patients with diabetic retinopathy (including macular edema), Parkview Health was able to combine annual eye exams for people with diabetes with routine diabetes care. Rather than referring patients out to an additional appointment with an eyecare specialist, LumineticsCore allowed them to provide the eye exam for diabetes to 86% of their patients, 46% of which tested positive for diabetic retinopathy and were immediately referred to an eyecare specialist to minimize the risk of vision loss.
Read more about how Parkview Health reduced their care gap for people with diabetes, created better opportunities for health equity, and identified eye disease early for more effective treatment in this comprehensive white paper.